Articles by Jill Wechsler - Pharmaceutical Executive


Articles by Jill Wechsler

Vaccines and Value

Feb 1, 2010

R&D is surging, but new methods and data raise new manufacturing and regulatory challenges.

Change Agent

Jan 6, 2010

FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?

The Big Shift

Jan 1, 2010

Pharma must confront regulatory and marketing challenges in a global competitive environment.

Go Go Generics

Dec 1, 2009

They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.

Congress Ups the Pharma Ante for Health Reform

Nov 24, 2009

House bill boosts rebates and opens the door to government price negotiations.

Risk and Restrictions

Nov 1, 2009

FDA and Congress weigh policies for improving drug safety via ads and written information.

Science and Safety

Oct 1, 2009

All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.

Going Global

Sep 1, 2009

Pharma steps up development of new vaccines and treatments to combat Third World diseases

Coverage Vs. Control

Aug 1, 2009

Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.


Click here